≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Osteonecrosis due to drugs

EFO Endpoint Browser PheWeb

OSTEON_DRUGS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M87.1#

1 out of 7 registries used, show all original rules.

403

4. Check minimum number of events

None

403

5. Include endpoints

None

403

6. Filter based on genotype QC (FinnGen only)

403

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1822 909 908
Only index persons 1748 891 857
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.03
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 67.96 67.79 68.14
Only index persons 68.30 68.00 68.61

-FinnGen-

Key figures

All Female Male
Number of individuals 403 198 205
Unadjusted period prevalence (%) 0.08 0.07 0.09
Median age at first event (years) 69.87 69.61 70.12

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
370
Matched controls
3701
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
+∞
323.0
370
*
M05BX04
ATC
denosumab; parenteral
48.0
167.0
208
96
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
13.6
105.7
299
873
H02AB02
ATC
dexamethasone; systemic
17.1
105.6
188
210
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
50.9
91.0
109
30
ECB20
NOMESCO Finland
Oral alveoplasty
76.0
82.5
92
16
SAA03
NOMESCO Finland
Extended examination of mouth
8.7
78.4
271
887
WF049
NOMESCO Finland
Radiotherapy of metastasis
27.2
76.9
108
55
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
22.7
76.9
115
72
A03FA01
ATC
metoclopramide; systemic, rectal
8.1
70.2
203
480
N02AA05
ATC
oxycodone; systemic
8.8
68.7
178
352
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
67.9
66.9
76
14
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
7.0
65.4
250
849
163
Kela drug reimbursment
Abiraterone and enzalutamide
78.0
62.9
70
11
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
17.9
50.5
81
57
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
5.4
49.8
254
1070
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
37.6
49.6
63
20
A04AA02
ATC
granisetron; systemic, transdermal
10.6
47.6
99
123
JN4BD
NOMESCO Finland
Extensive body CT
7.2
47.5
133
268
L02BB04
ATC
enzalutamide; oral
62.9
47.0
54
10
ZX120
NOMESCO Finland
Intravenous
7.6
44.1
115
206
ZX112
NOMESCO Finland
Subcutaneous
20.5
43.0
65
38
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
57.5
42.9
50
10
116
Kela drug reimbursment
Prostate cancer
9.7
42.3
92
122
352
Kela drug reimbursment
Abiraterone and enzalutamide
74.7
41.1
46
7
L02BX03
ATC
abiraterone; oral
65.3
40.3
46
8
L02BB03
ATC
bicalutamide; oral
16.6
39.1
64
46
L03AA02
ATC
filgrastim; parenteral
16.0
37.4
62
46
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
34.2
37.1
48
16
Z51.5
ICD-10 Finland
Palliative care
8.4
37.1
88
133
Y77
ICPC
Malignant neoplasm prostate
15.6
37.1
62
47
A04AA01
ATC
ondansetron; systemic, rectal
7.9
36.4
90
145
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.0
35.8
112
249
L02BA03
ATC
fulvestrant; parenteral
105.5
35.4
38
*
192
Kela drug reimbursment
Fulvestrant
136.5
35.4
37
*
JN4AD
NOMESCO Finland
Body CT examination
7.1
35.2
94
169
R50.9
ICD-10 Finland
Fever, unspecified
5.5
34.9
119
293
L02BX02
ATC
degarelix; parenteral
33.9
34.8
45
15
NK6AN
NOMESCO Finland
Total body bone isotope imaging
13.8
34.6
61
52
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
24.8
34.1
48
22
153
Kela drug reimbursment
Lenalidomid
62.0
34.0
39
7
L04AX04
ATC
lenalidomide; oral
70.2
33.7
38
6
C90.0
ICD-10 Finland
Multiple myeloma
28.3
33.2
45
18
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
+∞
32.8
31
*
K10.25
ICD-10 Finland
Sequences of jawbones
352.5
32.4
32
*
EDW99
NOMESCO Finland
Other operation on mandible
340.0
31.3
31
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
5.8
30.4
96
212
H02AB06
ATC
prednisolone; systemic
3.7
30.3
248
1322
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
62.1
29.7
34
6
C61
ICD-10 Finland
Malignant neoplasm of prostate
5.5
29.6
97
223
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.5
29.2
67
94
A79
ICPC
Malignancy NOS
24.7
28.5
40
18
K10.21
ICD-10 Finland
Osteoradionecrosis of jaw (acute)(chronic)(suppurative)
+∞
28.5
27
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
3.8
28.5
159
613
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
28.1
244
1326
L02AE02
ATC
leuprorelin; implant, parenteral
8.9
28.0
62
82
1501
Kela drug reimbursment
Palbociclib
104.6
27.1
29
*
WW500
NOMESCO Finland
Blood transfusion
9.7
26.7
56
67
XW000
NOMESCO Finland
Bone marrow biopsy
7.5
26.6
66
104
329
Kela drug reimbursment
Lenalidomide
100.7
26.0
28
*
5BA08
NOMESCO Finland
NA
36.0
26.0
33
10
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.8
25.7
57
75
TPH04
NOMESCO Finland
Cathetrisation of vein
3.7
25.4
142
536
XX3DW
NOMESCO Finland
Time consuming IT work
5.1
25.3
88
213
M87.0
ICD-10 Finland
Idiopathic aseptic necrosis of bone
75.3
25.2
28
*
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
7.0
25.1
65
109
394
Kela drug reimbursment
Palbociclib
96.8
25.0
27
*
L01XE33
ATC
[U] palbociclib; oral
267.2
25.0
25
*
A02BC02
ATC
pantoprazole; systemic
3.6
24.9
295
1934
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.8
24.6
54
70
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
6.7
23.4
62
107
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
43.1
23.0
28
7
EBA10
NOMESCO Finland
Surgical removal of tooth
5.0
22.6
79
191
L02BG06
ATC
exemestane; oral
16.5
22.5
36
24
X76
ICPC
Malignant neoplasm breast female
13.5
22.4
39
32
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
31.3
22.2
29
10
L03AA13
ATC
pegfilgrastim; parenteral
8.7
21.8
48
62
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.7
21.8
58
100
115
Kela drug reimbursment
Breast cancer
5.2
21.8
72
163
C03CA01
ATC
furosemide; systemic
3.1
21.6
163
751
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.0
21.5
62
119
WF004
NOMESCO Finland
Palliative radiotherapy
13.6
21.4
37
30
L02BA01
ATC
tamoxifen; oral
8.3
20.7
47
64
M87.9
ICD-10 Finland
Osteonecrosis, unspecified
51.1
20.4
24
5
L02BG04
ATC
letrozole; oral
5.8
20.1
60
120
EDB00
NOMESCO Finland
Partial excision of mandible
+∞
20.0
19
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
77.5
19.9
22
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.4
19.6
76
203
EDA10
NOMESCO Finland
Biopsy of mandible
73.8
18.9
21
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.4
18.7
59
126
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.7
18.6
212
1230
NF1AA
NOMESCO Finland
Hip X-ray examination
4.4
18.3
71
189
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
34.9
18.2
23
7
SAA02
NOMESCO Finland
Basic examination of mouth
2.7
18.0
262
1736
D70.82
ICD-10 Finland
Drug-induced neutropenia
13.4
18.0
31
25
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
17.8
92
315
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.9
17.4
79
242
B01AB05
ATC
enoxaparin; parenteral
2.7
17.2
159
804
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.4
17.2
53
110
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.6
17.1
219
1327
A28
ICPC
Limited function/disability NOS
3.3
17.0
97
356
WZC30
NOMESCO Finland
Teaching
3.5
17.0
90
311
N02BE01
ATC
paracetamol; systemic, rectal
4.4
16.9
345
2797
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
66.5
16.9
19
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.0
16.6
47
88
N03AX16
ATC
pregabalin; oral
2.9
16.5
124
549
M05BA06
ATC
ibandronic acid; systemic
16.3
16.4
26
17
L95
ICPC
Osteoporosis
7.4
16.2
39
58
SXC05
NOMESCO Finland
Other oral or dental procedure
6.6
16.2
42
70
WX110
NOMESCO Finland
Local anesthesy
2.7
16.0
275
1929
ZX090
NOMESCO Finland
Other technic of radiotherapy
7.4
15.9
38
56
SAA01
NOMESCO Finland
Simple examination of mouth
2.7
15.9
279
1980
L04AA06
ATC
mycophenolic acid; systemic
12.5
15.8
28
24
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
5.2
15.6
50
108
N02AJ06
ATC
codeine and paracetamol; systemic
2.5
15.5
169
923
127
Kela drug reimbursment
Transplant complication
13.9
15.4
26
20
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.7
15.4
129
605
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
9.1
15.3
32
38
WW300
NOMESCO Finland
Transfer of autologic stem cells
47.1
15.2
18
*
1CD02
NOMESCO Finland
NA
17.4
15.0
23
14
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
83.5
14.7
16
*
5BX04
NOMESCO Finland
NA
83.5
14.7
16
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.5
14.6
73
240
M05BA04
ATC
alendronic acid; oral
3.9
14.6
63
183
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
7.8
14.4
33
46
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
55.5
13.9
16
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
7.3
13.8
33
49
HAC20
NOMESCO Finland
Total mastectomy
5.8
13.8
39
73
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
11.6
13.7
25
23
1XX32
NOMESCO Finland
NA
78.1
13.7
15
*
EFA20
NOMESCO Finland
Decortication of jaws
+∞
13.6
13
*
K10.28
ICD-10 Finland
Other inflammatory condition of the jaws
145.0
13.5
14
*
J05AB11
ATC
valaciclovir; oral
3.4
13.5
71
243
L01CA04
ATC
vinorelbine; systemic
15.8
13.3
21
14
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
23.5
13.0
18
8
EBA00
NOMESCO Finland
Extraction of tooth
2.4
13.0
151
829
K08.3
ICD-10 Finland
Retained dental root
4.1
12.8
52
143
WX290
NOMESCO Finland
Other blockade of nerve
2.3
12.8
167
974
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
9.8
12.7
25
27
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.8
12.6
55
161
WW409
NOMESCO Finland
Other aferesis
134.3
12.5
13
*
M87.3
ICD-10 Finland
Other secondary osteonecrosis
134.3
12.5
13
*
393
Kela drug reimbursment
Pomalidomide
134.3
12.5
13
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.6
12.4
58
180
AA1AA
NOMESCO Finland
Head X-ray examination
16.6
12.3
19
12
SXC03
NOMESCO Finland
Other oral or dental procedure
16.6
12.3
19
12
J01DB01
ATC
cefalexin; oral
2.7
12.2
313
2491
M05BB03
ATC
alendronic acid and colecalciferol; oral
7.2
12.2
29
43
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.8
12.1
30
47
L04AD01
ATC
ciclosporin; systemic
8.9
12.0
25
30
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
5.2
12.0
37
77
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
48.3
12.0
14
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
5.0
11.9
38
82
JN4CD
NOMESCO Finland
Very extensive body CT
5.7
11.8
34
65
L01BC06
ATC
capecitabine; oral
5.8
11.8
33
61
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.7
11.7
40
93
L01EF01
ATC
palbociclib; oral
67.1
11.7
13
*
H02AB07
ATC
prednisone; oral
2.9
11.5
79
321
1507
Kela drug reimbursment
Pomalidomide
123.6
11.5
12
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.8
11.4
49
142
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
7.2
11.4
27
40
L04AX01
ATC
azathioprine; systemic
5.3
11.3
34
69
A06AD11
ATC
lactulose; oral
2.8
11.2
80
332
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
11.7
11.2
20
18
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
6.6
11.2
28
45
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
11.1
118
613
ZYC01
NOMESCO Finland
Remote contact by phone
5.2
11.0
34
71
N03AX12
ATC
gabapentin; oral
2.8
11.0
79
330
ZXA00
NOMESCO Finland
Right side
2.3
11.0
133
735
J05AB01
ATC
aciclovir; systemic
2.6
11.0
94
435
J01FF01
ATC
clindamycin; systemic
2.3
10.9
126
680
K05.31
ICD-10 Finland
Periodontitis pronounced
3.1
10.8
64
235
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
13.4
10.8
18
14
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.4
10.8
18
14
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
7.4
10.8
25
36
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.8
10.7
35
78
XX7FT
NOMESCO Finland
Radioyttrium therapy with connected antibody
61.8
10.7
12
*
L03AA14
ATC
lipegfilgrastim; parenteral
10.5
10.6
20
20
A06AH03
ATC
naloxegol; oral
10.5
10.6
20
20
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
4.9
10.5
34
75
L04AX06
ATC
pomalidomide; oral
113.0
10.5
11
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
10.5
184
1191
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
10.3
187
1223
SPF20
NOMESCO Finland
Temporary soling for filling
13.6
10.3
17
13
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
3.8
10.2
44
128
WW200
NOMESCO Finland
Immunization
6.4
10.2
26
43
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.1
10.2
213
1471
L04AA01
ATC
[U] ciclosporin; systemic
10.5
10.1
19
19
SPAT1254
SPAT
Administration of medicine
2.6
10.1
78
340
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
10.0
86
397
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
8.5
10.0
21
26
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
4.2
10.0
38
99
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
10.0
76
328
L02AE03
ATC
goserelin; implant
17.3
9.9
15
9
318
Kela drug reimbursment
Teriparatide
12.7
9.9
17
14
C50.99
ICD-10 Finland
Breast, unspecified
5.7
9.7
27
50
J01MA12
ATC
levofloxacin; systemic
2.4
9.7
96
477
ZXD05
NOMESCO Finland
Urgent procedure
2.2
9.7
131
751
B03XA02
ATC
darbepoetin alfa; parenteral
7.5
9.6
22
31
R4110
NOMESCO Finland
Physiotherapy
2.2
9.6
121
672
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.1
9.5
55
200
Z01.2
ICD-10 Finland
Dental examination
2.1
9.5
156
969
ECA99
NOMESCO Finland
Other incision or excision of gingiva and alveolus
102.5
9.5
10
*
XX7AT
NOMESCO Finland
Radiation therapy with Radium-223
102.5
9.5
10
*
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.5
9.5
33
79
3054
Kela drug reimbursment
NA
30.9
9.5
12
*
GA5AA
NOMESCO Finland
Rib X-ray examination
30.9
9.5
12
*
1523
Kela drug reimbursment
NA
30.9
9.5
12
*
WW402
NOMESCO Finland
Leucoferesis
+∞
9.4
9
*
A07AA02
ATC
nystatin; oral
3.5
9.4
44
137
M05BA02
ATC
clodronic acid; systemic
22.4
9.4
13
6
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
9.4
80
365
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
6.6
9.2
23
37
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
11.9
9.1
16
14
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
11.9
9.1
16
14
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
6.8
9.1
22
34
Z3226
NOMESCO Finland
Physiotherapist
2.4
9.1
85
407
ECW99
NOMESCO Finland
Other operation on gingiva or alveoli
37.7
9.1
11
*
-50
ICPC
Medication/prescr/renewal
4.5
9.0
31
73
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.6
9.0
41
125
M05BA07
ATC
risedronic acid; oral
5.2
9.0
27
55
SPAT1255
SPAT
Intravenous administration of medicine
3.4
8.9
43
137
B03XA01
ATC
erythropoietin; parenteral
13.0
8.9
15
12
B01AB10
ATC
tinzaparin; parenteral
3.2
8.9
46
155
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.1
8.9
27
56
WX199
NOMESCO Finland
Other local analgesia
5.4
8.6
25
49
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
8.6
64
272
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
5.6
8.6
24
45
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
20.6
8.5
12
6
H02AB09
ATC
hydrocortisone; systemic
5.5
8.5
24
46
M87.8
ICD-10 Finland
Other osteonecrosis
92.0
8.4
9
*
N05CF01
ATC
zopiclone; oral
2.0
8.3
133
808
WX892
NOMESCO Finland
Monitored bed care
3.1
8.3
46
160
Z2221
NOMESCO Finland
Medical doctor
2.1
8.3
117
673
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.4
8.2
39
124
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
12.1
8.1
14
12
H05AA02
ATC
teriparatide; parenteral
12.1
8.1
14
12
R06AE07
ATC
cetirizine; oral
1.9
8.1
163
1077
EDA00
NOMESCO Finland
Incision of mandible
17.7
8.1
12
7
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
34.1
8.1
10
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
22.6
8.1
11
5
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
8.0
50
191
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.3
8.0
39
126
N05BA04
ATC
oxazepam; oral
2.1
7.9
98
535
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.8
7.9
33
94
Z3231
NOMESCO Finland
Registered nurse
2.0
7.9
122
728
NF3AA
NOMESCO Finland
Femur X-ray examination
7.2
7.9
18
26
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
9.7
7.8
15
16
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
7.8
77
377
K12.2
ICD-10 Finland
Cellulitis and abscess of mouth
15.4
7.8
12
8
J01MA14
ATC
moxifloxacin; systemic
2.8
7.8
49
189
EEW99
NOMESCO Finland
Other operation on maxilla
45.9
7.7
9
*
1CX01
NOMESCO Finland
NA
45.9
7.7
9
*
L02BG03
ATC
anastrozole; oral
6.9
7.7
18
27
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
7.7
116
687
ZX108
NOMESCO Finland
Inhalation
12.2
7.6
13
11
J01MA02
ATC
ciprofloxacin; systemic
1.9
7.6
158
1050
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
7.6
57
243
Z2446
NOMESCO Finland
Social worker
3.3
7.6
37
120
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.2
7.5
22
44
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.2
7.5
39
132
P01AB01
ATC
metronidazole; oral, rectal
1.9
7.5
153
1009
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.9
7.5
16
21
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
81.6
7.4
8
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
7.4
69
329
G03HA01
ATC
cyproterone; systemic
13.7
7.4
12
9
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
13.7
7.4
12
9
X59
ICD-10 Finland
Exposure to unspecified factor
2.3
7.4
77
386
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
8.6
7.4
15
18
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
8.6
7.4
15
18
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
8.6
7.4
15
18
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
5.4
7.4
21
41
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.1
7.4
41
144
EDB99
NOMESCO Finland
Other excision on mandible
+∞
7.3
7
*
M87
ICD-10 Finland
Osteonecrosis
+∞
7.3
7
*
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
+∞
7.3
7
*
L01AA03
ATC
melphalan; systemic
+∞
7.3
7
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
16.1
7.3
11
7
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
16.1
7.3
11
7
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.2
7.2
26
65
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
30.6
7.2
9
*
EEA10
NOMESCO Finland
Biopsy of maxilla
30.6
7.2
9
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
30.6
7.2
9
*
AA1AD
NOMESCO Finland
CT of head and brain
2.0
7.1
107
628
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
10.3
7.1
13
13
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
10.3
7.1
13
13
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
7.2
7.1
16
23
J01CA04
ATC
amoxicillin; systemic
2.0
7.0
294
2451
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.5
6.9
14
17
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.7
6.8
44
173
ZXC40
NOMESCO Finland
Use of ultrasound
40.8
6.8
8
*
J01CE02
ATC
phenoxymethylpenicillin; oral
1.8
6.7
246
1934
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
3.5
6.7
30
91
L28
ICPC
Limited function/disability (L)
2.2
6.7
71
360
R60.0
ICD-10 Finland
Localized oedema
2.5
6.6
54
240
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
6.6
52
228
A29
ICPC
General symptom/complaint other
2.5
6.6
52
228
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
12.5
6.6
11
9
M19.2
ICD-10 Finland
Other secondary arthrosis
8.9
6.6
13
15
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
8.9
6.6
13
15
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
5.2
6.6
19
38
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
6.5
90
508
K02.1
ICD-10 Finland
Caries of dentine
1.8
6.5
197
1453
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
6.4
6.5
16
26
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
4.2
6.5
23
57
ZXA05
NOMESCO Finland
Left side
1.9
6.4
110
673
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
14.6
6.4
10
7
ECA20
NOMESCO Finland
Biopsy of gingiva
8.4
6.4
13
16
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
9.5
6.3
12
13
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
18.4
6.3
9
5
SPAT1088
SPAT
Blood transfusion
18.4
6.3
9
5
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
7.2
6.3
14
20
WZA90
NOMESCO Finland
Other doctors statement
2.0
6.3
93
540
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
6.3
6
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
6.3
6
*
EDC99
NOMESCO Finland
Other reconstructive operations on mandible
+∞
6.3
6
*
K05.30
ICD-10 Finland
Periodontitis complex
2.3
6.3
57
269
WX002
NOMESCO Finland
Sedation and analgesia
2.0
6.3
88
501
YNB10
NOMESCO Finland
Collection of stem cells for transplant
27.2
6.2
8
*
HA1AA
NOMESCO Finland
X-ray mammography
2.8
6.2
40
156
A01
ICPC
Pain general/multiple sites
2.9
6.2
36
132
A05AA02
ATC
ursodeoxycholic acid; oral
7.9
6.2
13
17
TKC20
NOMESCO Finland
Catheterisation of bladder
2.8
6.2
39
150
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.1
6.1
32
110
WX725
NOMESCO Finland
Noninvasive ventilation
3.7
6.1
25
71
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
6.1
45
188
B02.9
ICD-10 Finland
Zoster without complication
3.2
6.1
30
99
XF600
NOMESCO Finland
Bloodpressure measurement
2.9
6.1
35
128
ZX080
NOMESCO Finland
Image guided radiotherapy
6.2
6.1
15
25
WX402
NOMESCO Finland
General anaesthesia
2.2
6.0
64
322
A46
ICD-10 Finland
Erysipelas
2.2
6.0
64
323
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
6.0
35
129

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
265
1005
5.78
65.75
8.2
4.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
358
1794
9.92
63.50
27.2
6.8
mmol/l
1.2
1.2
0.56
316
1523
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
160
428
5.54
59.25
11.6
4.1
u/l
251.7
243.7
0.16
152
404
(3015377) Calcium [Moles/volume] in Serum or Plasma
283
1215
5.46
58.03
12.1
3.3
mmol/l
2.3
2.4
0.62
268
1045
(3042936) Bacteria identified in Isolate by Culture
174
532
5.00
54.19
2.5
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
318
1573
5.84
52.65
12.5
4.6
g/l
33.0
35.2
9.27
308
1465
(3013650) Neutrophils [#/volume] in Blood by Automated count
360
1992
8.57
51.79
39.5
9.1
e9/l
3.8
4.1
1.82
347
1748
(42870588) Differential panel, method unspecified - Blood
266
1158
4.82
51.59
13.7
5.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
181
600
4.66
50.24
7.6
3.4
mmol/l
0.8
0.8
1.13
173
564
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
318
1651
5.39
47.32
20.1
5.9
mmol/l
1.2
1.2
1.17
312
1486
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
179
613
4.45
47.08
2.9
1.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
46
39
13.19
46.22
4.5
2.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
53
58
10.37
44.92
8.6
6.9
iu/ml
577.1
161.0
1.94
16
11
(3002030) Lymphocytes/100 leukocytes in Blood
308
1640
4.72
42.16
16.0
5.8
%
24.2
27.2
4.62
302
1523
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
61
88
7.99
41.46
2.1
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
302
1597
4.56
41.43
15.8
5.7
%
2.4
2.8
3.56
295
1484
(3019069) Monocytes/100 leukocytes in Blood
302
1603
4.53
41.06
16.4
6.0
%
8.9
8.8
0.31
296
1498
(3018010) Neutrophils/100 leukocytes in Blood
301
1613
4.42
39.88
15.6
5.6
%
59.8
57.5
2.09
294
1509
(3003458) Phosphate [Moles/volume] in Serum or Plasma
143
466
4.21
39.20
10.8
4.8
mmol/l
1.0
1.0
0.12
136
432
(3019198) Lymphocytes [#/volume] in Blood
313
1738
4.59
39.10
15.2
5.5
e9/l
1.5
1.9
5.46
288
1526
(3001604) Monocytes [#/volume] in Blood
308
1694
4.47
38.91
15.0
5.5
e9/l
0.6
0.6
0.18
282
1456
(3037756) Immunofixation for Serum or Plasma
59
89
7.59
38.49
4.5
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
313
1756
4.50
38.07
16.1
5.7
e9/l
0.2
0.2
0.79
294
1540
(3006315) Basophils [#/volume] in Blood
307
1701
4.38
37.97
15.1
5.5
e9/l
0.0
0.0
3.22
281
1471
(3018418) pH of Serum or Plasma
235
1091
3.77
37.93
16.5
3.8
ph
7.4
7.4
0.69
51
204
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
57
86
7.56
37.14
2.2
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
59
94
7.18
36.57
14.7
4.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
98
255
4.76
35.80
2.1
1.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
47
60
8.74
35.22
15.7
2.9
u/ml
124.5
26.3
2.69
47
60
(3020779) Urea [Moles/volume] in Serum or Plasma
108
313
4.35
34.24
9.2
6.3
mmol/l
10.1
9.6
0.29
103
298
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
129
429
3.95
33.77
2.8
1.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
24
10
25.46
33.63
2.6
1.8
ug/l
55.1
63.8
—
24
10
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
128
433
3.87
32.56
2.8
1.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
27
18
16.01
30.79
3.7
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
44
61
7.97
30.72
2.3
2.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
62
124
5.73
30.48
19.3
4.0
mg/l
54.0
32.1
0.65
53
96
(3034860) Kappa light chains.free [Mass/volume] in Serum
62
124
5.73
30.48
19.3
4.0
mg/l
92.4
95.8
0.02
53
95
(3028026) IgM [Mass/volume] in Serum or Plasma
83
220
4.49
29.27
3.7
1.7
g/l
0.7
1.7
2.29
74
198
(3013826) Glucose [Moles/volume] in Serum or Plasma
331
2119
4.15
29.00
11.2
4.8
mmol/l
6.7
6.8
0.19
323
1999
(3000850) Epithelial cells [#/volume] in Urine
172
751
3.25
28.74
3.8
2.5
e6/l
4.3
4.6
0.12
160
659
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
131
5.41
28.65
14.2
1.9
g/l
7.6
10.5
4.68
49
111
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
41
57
7.89
28.51
1.7
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
269
1530
3.28
28.23
10.7
9.2
inr
1.2
1.3
0.37
75
430
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
40
55
7.96
28.07
1.7
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
135
5.25
27.67
15.1
1.8
g/l
3.1
3.2
0.23
47
104
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
144
5.09
27.50
14.8
1.8
g/l
3.7
3.7
0.01
45
103
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
144
5.09
27.50
14.8
1.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
144
5.09
27.50
14.8
1.8
g/l
7.6
7.5
0.15
46
108
(3017704) Immunofixation for Urine
26
20
13.83
27.37
3.3
2.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
144
580
3.31
27.32
2.8
2.3
umol/l
12.8
12.9
0.04
138
532
(3002582) Erythrocytes [#/volume] in Urine
216
1103
3.07
27.05
5.5
3.2
e6/l
599.2
114.6
0.46
191
852
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
132
507
3.38
27.03
3.0
2.3
%
23.4
22.3
0.31
114
436
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
273
1603
3.18
26.37
8.6
4.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
110
382
3.59
26.34
2.5
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
134
529
3.30
26.12
2.8
2.3
g/l
2.2
2.3
1.03
126
488
(3042111) Morphology [Interpretation] in Bone marrow Narrative
43
70
6.76
25.91
3.3
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
161
713
3.10
25.72
4.9
2.8
mosm/kgh2o
538.6
555.7
0.40
150
602
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
63
149
4.83
25.45
2.0
2.0
ug/l
2.0
4.0
0.45
57
130
(3004588) Protein electrophoresis panel - Serum or Plasma
87
265
3.91
25.21
13.9
2.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
39
60
7.09
24.74
4.0
3.9
%
2.1
1.0
0.97
28
52
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
238
1328
2.93
24.60
5.8
3.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
95
313
3.66
24.49
3.9
3.1
ng/l
195.9
214.6
0.17
87
287
(3002179) Metamyelocytes/100 leukocytes in Blood
85
265
3.80
23.73
4.7
4.4
%
1.1
0.5
2.06
29
73
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
36
54
7.22
23.35
1.6
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
226
1262
2.80
22.74
6.9
3.8
e6/l
75.2
88.9
0.20
194
909
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
28
32
9.33
22.68
16.5
2.6
u/ml
235.3
63.9
0.60
28
32
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
66
177
4.26
22.66
2.1
2.0
g/l
1.8
1.5
1.09
61
156
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
41
73
6.14
22.58
1.8
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
41
73
6.14
22.58
1.8
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
84
270
3.67
22.34
4.2
3.6
ng/l
70.6
76.6
0.26
74
241
(3044640) Blood type and Crossmatch panel - Blood
206
1106
2.76
22.25
5.7
2.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
155
720
2.87
22.11
4.9
3.9
ng/l
329.2
304.4
0.06
128
586
(3026008) Bacteria identified in Urine by Culture
203
1095
2.72
21.53
4.5
3.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
88
301
3.46
21.21
5.5
4.3
%
1.2
0.9
0.36
48
103
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
32
48
7.16
20.71
1.7
1.2
u/ml
118.6
98.1
—
7
7
(3037467) Urinalysis macro (dipstick) panel - Urine
335
2369
3.45
20.67
7.2
4.5
—
—
—
0
0
(44790047)
30
42
7.64
20.63
1.9
1.5
—
—
—
0
0
(44806118)
30
42
7.64
20.63
1.9
1.5
—
—
—
0
0
(44790048)
30
42
7.64
20.63
1.9
1.5
—
—
—
0
0
(44790049)
30
42
7.64
20.63
1.9
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
33
53
6.69
20.05
1.6
1.2
u/ml
238.1
278.2
0.23
22
30
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
25
29
9.12
19.98
2.7
2.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
147
695
2.76
19.92
6.3
3.1
mmol/l
2.5
2.5
0.89
133
610
(3023520) Reticulocytes [#/volume] in Blood
91
331
3.26
19.78
4.8
2.7
e9/l
72.2
71.1
0.08
75
257
(3030467) Casts [#/volume] in Urine by Automated count
188
1009
2.62
19.69
4.9
3.1
e6/l
0.4
0.5
0.41
164
752
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29
43
7.19
18.94
1.8
2.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
50
125
4.42
18.70
16.7
2.1
g/l
1.4
0.8
0.60
44
110
(3048929) Epstein Barr virus Ab [Presence] in Serum
40
83
5.24
18.68
1.5
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
163
833
2.61
18.67
4.8
2.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
76
257
3.41
18.51
2.7
2.3
nmol/l
4.5
13.3
11.81
58
227
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
28
41
7.26
18.49
1.8
2.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
23
27
8.97
18.19
1.4
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
166
865
2.56
18.16
31.6
6.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
231
1404
2.51
18.11
3.6
2.2
nmol/l
83.1
77.5
2.42
216
1225
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
21
22
10.02
18.03
1.5
2.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
21
22
10.02
18.03
1.5
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
21
22
10.02
18.03
1.5
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
21
22
10.02
18.03
1.5
2.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
68
218
3.55
17.96
1.7
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
49
6.53
17.92
2.4
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
67
5.63
17.83
1.8
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
28
43
6.92
17.70
1.3
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
168
893
2.51
17.48
2.7
2.1
mg/l
2.9
3.3
1.14
153
770
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
16
11.73
17.21
4.2
2.2
%
10.8
13.9
—
8
8
(4035726)
86
327
3.07
17.17
1.5
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
43
102
4.60
17.14
4.1
3.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
191
1099
2.40
16.43
9.5
3.3
u/l
43.3
33.2
0.78
180
1043
(3036481) Cortisol [Moles/volume] in Serum or Plasma
83
317
3.04
16.40
2.9
1.9
nmol/l
360.1
371.3
0.17
78
293
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
29
51
6.05
16.10
1.4
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
76
280
3.11
15.96
5.7
4.4
%
0.1
0.2
0.28
45
92
(3007164) IgA [Mass/volume] in Serum or Plasma
128
621
2.56
15.92
4.8
1.4
g/l
2.1
2.6
1.49
101
359
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
24
35
7.23
15.87
2.7
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
174
975
2.38
15.74
5.0
3.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
16
11.05
15.64
1.5
2.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
16
11.05
15.64
1.5
2.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
25
39
6.77
15.56
1.5
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
25
39
6.77
15.56
1.5
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
25
39
6.77
15.56
1.5
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
43
111
4.22
15.37
1.6
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
20
25
8.37
15.02
2.8
2.1
e6/l
432.6
700.9
—
5
11
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
17
10.40
15.01
1.5
2.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
123
603
2.50
14.82
4.7
2.9
e6/l
3.9
2.0
0.90
77
331
(3017817) Protein [Mass] in Urine collected for unspecified duration
23
35
6.91
14.63
3.0
2.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
50
150
3.66
14.50
2.7
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
218
1384
2.25
14.26
4.3
2.6
ug/l
279.7
144.4
5.83
204
1254
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
91
392
2.71
14.25
8.6
2.9
umol/l
7.5
9.9
0.40
82
347
(3002032) Base excess in Venous blood by calculation
83
342
2.80
14.15
8.5
3.3
mmol/l
1.8
2.0
0.23
67
271
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
16
16
10.37
14.11
2.3
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
16
16
10.37
14.11
2.3
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
81
330
2.82
14.11
2.0
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
70
264
3.00
14.03
5.0
4.5
%
0.4
0.1
0.45
34
77
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
13
10
13.40
13.43
1.7
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
18
23
8.15
13.25
1.7
2.8
%
32.7
45.6
—
7
8
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
46
140
3.58
13.03
2.3
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
183
1114
2.18
12.92
3.3
2.4
u/l
51.8
56.5
0.92
175
1022
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
60
217
3.07
12.89
1.5
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
19
27
7.34
12.81
4.4
2.2
e9/l
0.9
1.0
0.11
12
13
(3021589) Normoblasts [#/volume] in Blood
229
1527
2.16
12.72
27.7
9.6
e9/l
0.0
0.0
0.46
198
1255
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
26
52
5.28
12.59
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
52
5.28
12.59
1.9
1.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
23
41
5.89
12.56
4.0
3.5
%
61.8
55.0
0.46
14
31
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
136
742
2.26
12.54
3.0
1.8
mg/l
1.2
1.3
0.25
113
581
(3019309) Folate [Moles/volume] in Red Blood Cells
130
702
2.26
12.24
1.8
1.7
nmol/l
1018.6
1213.0
1.63
113
529
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
38
106
3.85
12.20
6.5
2.6
g/l
3.4
3.7
0.63
38
101
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
20
32
6.52
12.12
1.1
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
82
362
2.59
12.09
2.0
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
13
12
11.16
12.02
2.5
2.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
75
4.39
12.01
1.5
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
59
4.83
11.83
2.0
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
37
104
3.82
11.75
1.9
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
62
241
2.86
11.68
4.8
3.9
ph
7.4
7.4
—
7
25
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
60
4.75
11.60
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
56
4.89
11.58
1.8
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
73
311
2.65
11.54
12.4
8.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
59
225
2.90
11.51
4.8
4.0
mmol/l
1.5
2.1
0.49
48
175
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
389
3358
5.56
11.33
53.9
15.4
mg/l
26.3
23.8
0.91
370
2693
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
86
400
2.46
11.31
7.7
4.6
ug/l
36.4
40.6
0.05
75
345
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
18
28
6.68
11.18
1.1
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
16
9.03
11.18
5.3
2.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
23
46
5.24
11.13
1.6
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
120
3.49
10.85
3.2
2.6
u/ml
0.4
0.4
0.02
21
68
(40760892) CBC W Ordered Manual Differential panel - Blood
130
732
2.15
10.83
8.0
4.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
41
132
3.34
10.63
3.1
3.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
37
5.64
10.50
1.1
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
87
420
2.37
10.48
2.0
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
203
1366
1.98
10.21
2.5
2.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
59
240
2.71
10.16
1.9
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
15
9
17.24
9.94
1.5
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
13
9.48
9.92
1.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
12
13
9.48
9.92
4.5
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
31
87
3.78
9.86
1.8
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
67
295
2.52
9.83
14.6
3.6
mmol/l
1.2
1.2
0.16
67
258
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
179
1166
1.96
9.78
4.3
3.2
ng/l
2212.5
1283.5
0.57
163
998
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
51
196
2.83
9.77
11.1
10.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
11
10.25
9.58
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
11
10.25
9.58
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
32
94
3.61
9.53
1.7
1.4
—
—
—
0
0
(3019225) pH of Specimen
77
367
2.36
9.49
16.9
4.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
114
638
2.10
9.48
3.8
2.7
e6/l
0.9
1.0
0.27
69
360
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
72
335
2.40
9.36
2.4
2.5
u/l
28.3
32.2
0.62
61
282
(3024980) IgG subclass 4 [Mass/volume] in Serum
21
46
4.76
9.17
1.3
1.8
g/l
0.6
1.0
0.47
16
38
(3000494) Fungus identified in Specimen by Culture
86
438
2.22
9.05
2.0
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
13
18
7.43
8.89
1.0
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
74
362
2.28
8.55
2.0
2.1
g/l
0.2
0.2
0.21
74
340
(3035933) Granulocytes/100 leukocytes in Blood
11
13
8.67
8.50
2.2
1.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
85
443
2.16
8.41
1.5
1.3
titre
842.0
525.4
0.56
20
104
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
30
5.51
8.27
1.1
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
85
447
2.14
8.20
9.1
7.6
mmol/l
1.8
1.2
0.63
71
364
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
38
4.91
8.19
3.1
2.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
25
69
3.80
8.14
1.3
1.2
u/l
76.3
17.5
1.72
25
59
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
12
8
15.41
7.76
3.7
2.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
272
2128
1.86
7.64
4.4
3.2
u/l
105.2
53.1
2.45
260
1960
(3028433) Virus identified in Specimen by Culture
12
18
6.84
7.64
1.2
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
25
5.77
7.59
1.1
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
24
68
3.69
7.54
3.5
2.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
33
5.01
7.47
1.3
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
50
4.16
7.43
1.4
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
28
90
3.27
7.28
2.1
1.5
e6/l
21489.9
14816.7
0.18
20
67
(3044941) Cell count panel - Synovial fluid
20
51
4.07
7.25
2.2
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
23
5.81
7.11
1.7
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
44
185
2.55
7.07
5.5
3.9
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
17
39
4.51
7.02
1.3
1.3
e6/l
3341.3
1542.8
0.29
12
28
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
48
4.10
6.97
5.1
4.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
25
78
3.35
6.82
1.6
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
235
1806
1.72
6.54
3.1
2.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
25
5.34
6.53
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
29
4.97
6.50
4.5
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
18
6.25
6.46
2.2
2.2
u/ml
524.2
903.8
0.97
11
18
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
10
7
14.60
6.43
4.5
2.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
7
14.60
6.43
1.4
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
33
128
2.72
6.22
4.2
3.4
g/l
1.6
0.2
0.60
19
54
(3045424) Erythrocytes [Presence] in Urine
18
48
3.88
6.15
1.6
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
135
904
1.74
6.10
1.7
1.5
nmol/l
18.5
20.9
1.38
122
754
(3022217) INR in Platelet poor plasma by Coagulation assay
86
502
1.91
6.10
18.5
22.9
inr
1.2
1.2
0.04
27
68
(3044290) Cell count panel - Cerebral spinal fluid
20
58
3.58
6.09
4.0
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
21
63
3.46
6.08
2.4
2.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
199
1485
1.67
5.99
2.5
2.0
pmol/l
85.6
95.7
2.47
128
754
(3025941) Bacteria identified in Stool by Culture
40
174
2.44
5.99
1.4
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
27
96
2.94
5.96
3.0
2.4
mmol/l
24.9
25.0
0.04
22
82
(3026389) Candida sp identified in Specimen by Organism specific culture
16
40
4.12
5.95
1.1
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
15
36
4.29
5.87
1.3
1.3
e6/l
5782.8
41071.5
—
9
22
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
32
4.50
5.81
1.3
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
127
853
1.71
5.61
1.8
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
25
4.92
5.53
3.8
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
25
4.92
5.53
3.0
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
36
156
2.44
5.44
1.4
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
302
2550
1.74
5.39
7.6
4.2
mm/h
21.4
12.9
8.00
292
2333
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
190
1432
1.62
5.29
4.8
3.9
ng/l
38.7
60.1
0.44
149
1069
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
22
5.11
5.29
3.3
1.9
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
0
+∞
5.22
4.6
0.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
65
3.19
5.14
4.5
3.1
%
54.5
58.9
0.64
20
65
(4062490)
12
27
4.55
5.07
1.4
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
133
926
1.65
5.04
7.9
2.6
umol/l
339.1
8777.7
4.83
126
786
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
100
2.71
5.00
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
69
1103
0.55
4.94
3.2
3.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
152
1099
1.62
4.94
2.6
2.1
u/l
144.7
278.3
1.12
145
1025
(3024928) Oxygen saturation in Venous blood
22
78
2.93
4.90
9.2
2.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
62
3.17
4.85
4.1
2.6
e9/l
3.4
4.5
1.44
19
62
(3023419) Bacteria identified in Sputum by Culture
18
57
3.26
4.82
1.8
2.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
7
11.63
4.80
1.3
3.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
68
3.04
4.78
1.9
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
85
2.81
4.76
1.5
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
213
1681
1.57
4.69
6.8
5.2
estimate
0.0
0.0
0.00
58
303
(3019230) Fractional oxyhemoglobin in Venous blood
20
69
3.00
4.67
8.9
1.7
%
56.1
62.7
0.57
20
69
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
25
4.50
4.59
2.1
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
25
4.50
4.59
2.1
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
9
11
8.34
4.58
3.8
4.8
%
59.9
46.5
—
9
11
(3044889) 12 lead EKG panel
292
2487
1.63
4.57
5.2
4.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
19
65
3.02
4.50
3.5
1.1
mmol/l
4.2
3.9
0.15
19
60
(3036489) Thrombin time
30
131
2.39
4.48
6.8
2.2
s
21.9
21.6
0.13
30
121
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
12
7.64
4.37
1.6
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
213
1701
1.53
4.31
5.2
3.8
estimate
0.0
0.0
0.50
55
289
(3045788) Cell count panel - Pleural fluid
12
31
3.96
4.28
1.2
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
13
7.05
4.18
1.0
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
68
2.88
4.18
3.7
2.3
%
17.1
15.7
0.92
11
34
(3024471) HLA-A [Type]
7
7
10.15
4.02
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
7
10.15
4.02
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
28
4.01
4.00
10.7
1.7
%
9.9
10.6
0.23
11
28
(3035350) Ketones [Presence] in Urine by Test strip
208
1671
1.51
3.98
5.1
3.8
estimate
0.0
0.0
0.00
51
306
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
15
48
3.21
3.97
2.7
1.9
pg
33.3
33.1
0.09
15
48
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
19
71
2.76
3.88
1.2
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
5
12.15
3.77
1.7
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
5
12.15
3.77
1.2
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
103
2.41
3.74
1.7
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
57
340
1.79
3.73
2.1
2.6
ug/l
8.4
6.3
0.27
49
300
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
25
4.08
3.72
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
63
388
1.74
3.69
5.0
3.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
12
6.77
3.69
2.0
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
12
6.77
3.69
3.6
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
16
5.73
3.68
1.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
47
265
1.88
3.67
6.8
4.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
23
98
2.43
3.64
1.9
1.3
—
—
—
0
0
(3013512) EKG study
145
1101
1.50
3.55
5.0
4.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
26
3.92
3.54
5.7
3.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
392
3716
3.01
3.53
74.7
22.6
e9/l
243.9
243.4
0.04
387
3617
(40768446) Kidney Pathology biopsy report
6
6
10.12
3.51
2.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
36
3.40
3.50
1.7
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
12
36
3.40
3.50
1.2
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
36
3.40
3.50
5.6
3.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
23
100
2.38
3.50
1.3
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
42
232
1.90
3.50
4.5
2.7
e9/l
3.4
4.2
1.89
37
175
(3026361) Erythrocytes [#/volume] in Blood
392
3718
2.99
3.48
74.5
22.6
e12/l
4.0
4.5
43.83
386
3602
(3010813) Leukocytes [#/volume] in Blood
392
3718
2.99
3.48
74.5
22.7
e9/l
6.5
6.7
0.83
387
3605
(3003327) Ova and parasites identified in Stool by Light microscopy
22
95
2.39
3.40
1.8
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
10
7.10
3.37
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
66
2.65
3.25
2.5
2.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
33
3.40
3.21
1.0
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
15
5.42
3.20
3.0
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
48
285
1.78
3.19
6.1
3.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
22
98
2.32
3.19
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
200
0.29
3.16
1.7
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
99
2.29
3.12
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
68
448
1.62
3.10
1.5
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
93
2.33
3.09
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
39
220
1.86
3.06
1.2
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
16
5.08
3.06
3.7
2.4
nmol/l
96.1
71.0
—
8
16
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
12
5.92
3.03
2.4
6.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
51
2.81
3.01
1.8
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
69
2.53
3.00
1.2
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
5
10.10
2.98
1.8
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
5
10.10
2.98
1.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
5
10.10
2.98
1.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
5
10.10
2.98
8.2
2.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
5
10.10
2.98
1.0
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
56
355
1.67
2.96
2.8
2.2
ug/g
150.4
147.5
0.03
48
278
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
17
4.78
2.93
3.4
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
52
2.75
2.92
1.8
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
52
2.75
2.92
1.8
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
328
2979
1.54
2.90
56.6
16.7
%
35.0
39.7
10.59
219
2005
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
13
5.46
2.88
2.1
2.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
223
0.35
2.88
1.8
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
119
901
1.46
2.86
5.1
3.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
53
2.70
2.82
1.8
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
53
2.70
2.82
1.8
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
53
2.70
2.82
1.8
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
18
4.51
2.81
3.4
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
23
3.98
2.79
4.2
3.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
6
8.42
2.75
1.0
1.0
—
—
—
0
0
(3010421) pH of Blood
19
85
2.30
2.75
5.0
2.8
ph
7.4
7.4
0.39
19
69
(3045414) Leukocytes [Presence] in Urine
27
140
2.00
2.72
1.7
1.9
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
21
99
2.18
2.70
1.6
1.5
iu/ml
0.0
0.2
0.65
12
19
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
94
687
1.48
2.69
1.4
1.2
u/ml
0.7
1.4
1.14
21
177
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
19
4.27
2.69
1.5
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
17
73
2.39
2.69
1.6
1.5
iu/l
5.8
6.5
—
8
21
(3003338) MCHC [Mass/volume]
305
2751
1.45
2.59
67.0
20.3
g/l
328.8
332.2
7.92
305
2738
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
7
7.21
2.55
1.0
1.1
%
104.2
109.9
—
5
7
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
11
5.52
2.55
2.0
2.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
26
3.52
2.49
1.1
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
29
160
1.88
2.47
1.1
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
12
5.06
2.41
1.3
1.8
%
128.2
104.8
—
6
12
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
8
6.31
2.38
1.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
321
3431
0.68
2.34
4.8
5.3
mmol/l
2.6
2.7
0.37
292
3113
(3022806) Fractional oxyhemoglobin in Capillary blood
11
41
2.73
2.29
2.9
2.1
%
90.4
90.4
0.01
11
41
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
23
3.53
2.28
3.4
1.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
23
3.53
2.28
2.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
23
3.53
2.28
2.0
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
13
4.67
2.28
3.8
3.9
u/l
180.3
232.1
—
6
13
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
13
4.67
2.28
1.0
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
73
2.24
2.24
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
345
3215
1.51
2.21
47.8
14.6
ml/min/173m2
79.5
77.3
1.00
315
2669
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
311
3333
0.71
2.16
4.4
4.7
mmol/l
1.4
1.5
0.32
285
3019
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
28
160
1.81
2.16
2.1
2.3
u/l
35.9
38.3
0.23
23
143
(3002256) Pathology report gross observation
63
445
1.49
2.13
1.3
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
43
2.60
2.11
1.1
1.8
—
—
—
0
0
(3035880) pH of Pleural fluid
7
20
3.54
2.06
1.4
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
148
0.33
2.04
1.4
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
28
163
1.77
2.04
2.0
2.8
—
—
—
0
0
(3004451) EKG impression Narrative
7
21
3.37
1.97
1.6
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
45
2.48
1.94
1.1
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
369
3509
1.61
1.93
42.2
14.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
315
3351
0.73
1.85
4.5
4.7
mmol/l
4.6
4.6
0.26
292
3063
(21491868) Cryoglobulin [Mass/volume] in Serum
6
17
3.57
1.84
1.2
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
17
3.57
1.84
1.3
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
17
3.57
1.84
1.3
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
161
1360
1.31
1.84
17.2
5.1
ug/l
22.3
2.4
4.08
153
1203
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
12
4.20
1.83
1.2
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
53
2.30
1.82
1.3
3.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
147
1.75
1.78
1.3
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
18
3.37
1.75
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
36
2.53
1.75
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
40
268
1.55
1.74
3.1
2.6
ml/min/173m2
57.6
62.6
0.38
16
109
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
48
2.33
1.72
3.9
4.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
19
3.19
1.66
1.7
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
14
3.60
1.62
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
43
2.36
1.61
1.4
1.7
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
8
32
2.53
1.60
1.5
1.3
u/l
317.5
337.1
—
8
32
(3035320) C reactive protein [Mass/volume] in Body fluid
6
20
3.03
1.58
3.0
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
302
3214
0.76
1.57
4.3
4.2
mmol/l
1.5
1.3
4.53
277
2899
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
57
2.14
1.56
1.1
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
44
2.31
1.54
1.3
1.4
nmol/l
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
16
88
1.85
1.43
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
76
949
0.75
1.41
1.8
1.6
mmol/l
1.6
1.4
1.63
70
774
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
74
1.92
1.40
6.8
4.1
mg/l
21.4
32.5
—
9
46
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
29
2.44
1.40
1.3
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
448
0.67
1.37
16.2
7.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
129
1097
1.26
1.33
8.9
4.4
%
21.4
21.2
0.06
79
524
(1002224) Polysomnography panel
5
117
0.42
1.27
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
148
1286
1.24
1.25
5.8
4.1
—
—
—
0
0
(4010399)
38
272
1.44
1.25
1.6
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
25
2.42
1.25
1.3
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
25
2.42
1.25
2.7
4.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
9
45
2.02
1.24
1.7
7.8
mmol/l
5.6
6.3
—
9
36
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
10
49
2.07
1.23
1.3
1.4
nmol/l
0.5
0.6
—
10
44
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
94
781
1.27
1.17
1.7
1.8
pmol/l
422.2
438.4
0.22
85
640
(3005570) Glucose [Moles/volume] in Urine
7
31
2.28
1.11
3.6
2.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
145
1.55
1.08
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
46
1.98
1.04
1.3
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
35
2.02
1.00
1.4
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
107
919
1.22
0.99
6.7
4.1
estimate
0.0
0.0
0.00
52
292
(3017569) Oxygen content in Arterial blood
5
23
2.19
0.98
2.8
4.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
27
192
1.44
0.95
2.4
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
37
1.91
0.94
1.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
93
792
1.23
0.94
4.6
3.1
ug/l
1.7
0.7
1.61
73
519
(3011397) Hemoglobin [Presence] in Urine by Test strip
93
793
1.22
0.93
4.6
3.7
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
28
2.16
0.92
1.2
1.3
—
24.0
—
0
5
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
64
1.74
0.87
1.7
1.4
—
—
—
0
0
(4281824)
6
31
1.95
0.84
1.3
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
59
486
1.25
0.81
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
34
1.78
0.76
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
34
1.78
0.76
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
34
1.78
0.76
1.3
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
39
1.81
0.73
1.3
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
86
748
1.19
0.71
5.8
4.2
kg/l
1.0
1.0
0.65
16
107
(3022621) pH of Urine by Test strip
30
231
1.32
0.70
3.2
2.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
310
3214
0.85
0.70
6.2
6.3
mmol/mol
40.6
40.5
0.08
297
2952
(1761482) Bacteria [#/volume] in Urine by Culture
15
102
1.49
0.68
4.9
5.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
28
1.80
0.66
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
104
1.46
0.63
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
63
1.60
0.62
1.5
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
20
0.00
0.60
0.0
2.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
195
0.71
0.57
1.4
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
108
1191
0.87
0.57
5.1
4.0
mg/mmol
19.1
8.7
0.85
73
734
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
39
469
0.81
0.56
4.8
4.8
%
33.0
31.7
0.28
28
303
(4094501)
5
89
0.56
0.56
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
55
1.46
0.56
1.6
3.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
61
527
1.19
0.56
1.3
1.3
u/ml
5.1
13.3
0.99
17
198
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
28
222
1.28
0.55
2.6
2.6
—
10.9
—
0
8
(3022145) Colonoscopy Study observation
47
397
1.21
0.54
1.6
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
39
1.55
0.53
1.2
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
266
2549
1.13
0.53
4.8
3.7
pmol/l
14.9
14.9
0.02
248
2262
(3003740) Influenza virus B Ag [Presence] in Specimen
6
40
1.51
0.52
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
40
1.51
0.52
1.2
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
7
48
1.47
0.47
1.7
1.3
mu/l
70.5
50.2
—
7
43
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
85
0.58
0.45
1.0
2.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
6
91
0.65
0.43
2.3
1.8
nmol/l
43.8
42.4
—
6
84
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
16
0.00
0.41
0.0
2.6
—
13.5
—
0
16
(40768793) Breast Pathology biopsy report
11
79
1.40
0.41
1.3
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
28
332
0.83
0.38
1.4
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
16
125
1.29
0.37
1.6
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
(4306422)
6
42
1.43
0.35
1.2
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
47
1.28
0.32
1.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(4034850)
9
116
0.77
0.28
12.6
10.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
106
1124
0.92
0.27
6.1
3.2
mg/l
3955.6
156.1
2.29
76
714
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
180
0.83
0.24
1.2
1.2
iu/ml
52.0
136.1
—
5
65
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
40
1.25
0.22
1.2
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
41
1.22
0.22
1.4
1.1
—
3.8
—
0
15
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
202
1.15
0.20
1.6
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3000492) Spirometry study
27
302
0.89
0.20
2.1
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
183
0.87
0.16
1.5
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
35
376
0.92
0.13
1.5
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
306
3093
0.96
0.12
5.6
4.6
mu/l
1.9
2.0
0.34
286
2771
(3000330) Specific gravity of Urine by Test strip
20
181
1.11
0.12
4.0
4.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
58
553
1.06
0.12
1.5
1.3
iu/ml
36.8
37.8
0.02
17
178
(3020891) Body temperature
17
154
1.11
0.10
4.2
4.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
119
1164
1.03
0.08
4.3
3.1
mmol/l
6.4
7.3
2.21
107
948
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
64
0.78
0.08
1.4
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
32
333
0.96
0.05
1.8
1.6
%
1.6
1.6
0.05
24
289
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
201
0.94
0.04
1.5
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
28
292
0.96
0.04
7.5
3.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
332
3334
0.98
0.04
5.1
4.9
mmol/l
6.0
6.1
0.21
304
3016
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
51
0.98
0.00
1.0
1.1
—
25.8
—
0
9
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
14.4
—
0
6
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
68
0.88
0.00
2.2
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.2
—
0
6
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
78
0.90
0.00
2.0
2.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint OSTEON_DRUGS and mortality.

Females

Parameter HR [95% CI] p-value
OSTEON_DRUGS 6.288 [4.04, 9.8] < 0.001
Birth year 0.993 [0.98, 1.0] 0.139

During the follow-up period (1.1.1998 — 31.12.2019), 259 out of 709 females with OSTEON_DRUGS died.

Males

Parameter HR [95% CI] p-value
OSTEON_DRUGS 7.082 [4.47, 11.23] < 0.001
Birth year 0.985 [0.97, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 330 out of 697 males with OSTEON_DRUGS died.

Mortality risk

Mortality risk for people of age

years, who have OSTEON_DRUGS.

N-year risk Females Males
1 0.545% 1.567%
5 3.374% 8.081%
10 8.458% 18.232%
15 15.072% 31.532%
20 25.297% 48.531%

Relationships between endpoints

↥

Index endpoint: OSTEON_DRUGS – Osteonecrosis due to drugs

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data